Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Equity (2016 - 2025)

Historic Return on Equity for Mimedx (MDXG) over the last 14 years, with Q2 2025 value amounting to 0.0%.

  • Mimedx's Return on Equity fell 100.0% to 0.0% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.0%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.0% for FY2024, which is 1500.0% up from last year.
  • According to the latest figures from Q2 2025, Mimedx's Return on Equity is 0.0%, which was down 100.0% from 0.0% recorded in Q1 2025.
  • In the past 5 years, Mimedx's Return on Equity ranged from a high of 12.89% in Q1 2021 and a low of 0.13% during Q4 2023
  • In the last 5 years, Mimedx's Return on Equity had a median value of 0.66% in 2023 and averaged 2.12%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 134200bps in 2021, then plummeted by -89700bps in 2022.
  • Quarter analysis of 5 years shows Mimedx's Return on Equity stood at 4.3% in 2021, then tumbled by -75bps to 1.06% in 2022, then crashed by -112bps to 0.13% in 2023, then soared by 102bps to 0.0% in 2024, then tumbled by -54bps to 0.0% in 2025.
  • Its Return on Equity was 0.0% in Q2 2025, compared to 0.0% in Q1 2025 and 0.0% in Q4 2024.